跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOGROYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 5MG/1.5ML - HSA Drug Approval Details
Approvals
/
HSA
/
SOGROYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 5MG/1.5ML
Approved
THERAPEUTIC
SOGROYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 5MG/1.5ML
Novo Nordisk A/S (Formulation, Filling and Primary packager)
🇸🇬 Health Sciences Authority
Approval Date
Apr 14, 2025
Approval ID
e3b5f8b03fc5b23f
Company
Novo Nordisk A/S (Formulation, Filling and Primary packager)
Type
Therapeutic
Approval Details
Approval Id
e3b5f8b03fc5b23f
Drug Name
SOGROYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 5MG/1.5ML
Product Name
SOGROYA SOLUTION FOR INJECTION IN PRE-FILLED PEN 5MG/1.5ML
Approval Number
SIN17216P
Approval Date
2025-04-14
Registrant
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBCUTANEOUS
Atc Code
H01AC07
Pharma Manufacturer Name
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Company Detail Path
/organization/novo-nordisk-pharma-singapore-pte-ltd
Active Ingredients
Somapacitan
5mg/1.5ml
Somapacitan
5mg/1.5ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 14, 2025
Approval ID
e3b5f8b03fc5b23f
Type
Therapeutic
Back to HSA Approvals
